Medicina neonatal
Manejo da hiperbilirrubinemia
Fototerapia
Randomised controlled trial of single phototherapy with reflecting curtains versus double phototherapy in term newborns with hyperbilirubinaemia. (abre nova janela)
Fonte: J Paediatr Child Health 2013;49(5):375-9.
Indexado: PubMed 23573836
DOI: 10.1111/jpc.12192
https://www.ncbi.nlm.nih.gov/pubmed/23573836 (abre nova janela)
Effect of white plastic cover around the phototherapy unit on hyperbilirubinemia in full term neonates. (abre nova janela)
Fonte: Iran J Pediatr 2013;23(2):143-8.
Indexado: PubMed 23724173
https://www.ncbi.nlm.nih.gov/pubmed/23724173 (abre nova janela)
Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. (abre nova janela)
Fonte: Pediatrics 2011;128(4):e1046-52.
Indexado: PubMed 21949150
DOI: 10.1542/peds.2011-1494
https://www.ncbi.nlm.nih.gov/pubmed/21949150 (abre nova janela)
High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia. (abre nova janela)
Fonte: Acta Paediatr 2011;100(4):620-3.
Indexado: PubMed 21251060
DOI: 10.1111/j.1651-2227.2011.02170.x
https://www.ncbi.nlm.nih.gov/pubmed/21251060 (abre nova janela)
Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. (abre nova janela)
Fonte: Arch Dis Child Fetal Neonatal Ed 2006;91(6):F439-42.
Indexado: PubMed 16877479
DOI: 10.1136/adc.2006.095687
https://www.ncbi.nlm.nih.gov/pubmed/16877479 (abre nova janela)
Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. (abre nova janela)
Fonte: Cochrane Database Syst Rev 2012;(12):CD009017.
Indexado: PubMed 23235669
DOI: 10.1002/14651858.CD009017.pub2
https://www.ncbi.nlm.nih.gov/pubmed/23235669 (abre nova janela)
Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. (abre nova janela)
Fonte: Cochrane Database Syst Rev 2011;(12):CD007969.
Indexado: PubMed 22161417
DOI: 10.1002/14651858.CD007969.pub2
https://www.ncbi.nlm.nih.gov/pubmed/22161417 (abre nova janela)
Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. (abre nova janela)
Fonte: J Perinatol 2013;33(2):126-33.
Indexado: PubMed 22499082
DOI: 10.1038/jp.2012.39
https://www.ncbi.nlm.nih.gov/pubmed/22499082 (abre nova janela)
Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. (abre nova janela)
Fonte: Cochrane Database Syst Rev 2012;(1):CD007966.
Indexado: PubMed 22258977
DOI: 10.1002/14651858.CD007966.pub2
https://www.ncbi.nlm.nih.gov/pubmed/22258977 (abre nova janela)
The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. (abre nova janela)
Fonte: Indian J Med Sci 2009;63(5):174-9.
Indexado: PubMed 19584487
DOI: 10.4103/0019-5359.53162
https://www.ncbi.nlm.nih.gov/pubmed/19584487 (abre nova janela)
A randomized trial of phototherapy with filtered sunlight in African neonates. (abre nova janela)
Fonte: N Engl J Med 2015;373(12):1115-24.
Indexado: PubMed 26376136
DOI: 10.1056/NEJMoa1501074
https://www.ncbi.nlm.nih.gov/pubmed/26376136 (abre nova janela)
Dose-response relationship of phototherapy for hyperbilirubinemia. (abre nova janela)
Fonte: Pediatrics 2012;130(2):e352-7.
Indexado: PubMed 22802603
DOI: 10.1542/peds.2011-3235
https://www.ncbi.nlm.nih.gov/pubmed/22802603 (abre nova janela)
Imunoglobulina intravenosa
High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. (abre nova janela)
Fonte: Acta Paediatr 1999;88(2):216-9.
Indexado: PubMed 10102158
https://www.ncbi.nlm.nih.gov/pubmed/10102158 (abre nova janela)
High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. (abre nova janela)
Fonte: J Int Med Res 1995;23(4):264-71.
Indexado: PubMed 7589769
DOI: 10.1177/030006059502300406
https://www.ncbi.nlm.nih.gov/pubmed/7589769 (abre nova janela)
Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. (abre nova janela)
Fonte: Arch Dis Child Fetal Neonatal Ed 2003;88(1):F6-10.
Indexado: PubMed 12496219
https://www.ncbi.nlm.nih.gov/pubmed/12496219 (abre nova janela)
Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy. (abre nova janela)
Fonte: Biol Neonate 1996;70(2):69-74.
Indexado: PubMed 8864425
https://www.ncbi.nlm.nih.gov/pubmed/8864425 (abre nova janela)
Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility. (abre nova janela)
Fonte: Acta Paediatr 2008;97(10):1362-5.
Indexado: PubMed 18616629
DOI: 10.1111/j.1651-2227.2008.00915.x
https://www.ncbi.nlm.nih.gov/pubmed/18616629 (abre nova janela)
Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. (abre nova janela)
Fonte: J Matern Fetal Neonatal Med 2004;16(3):163-6.
Indexado: PubMed 15590442
DOI: 10.1080/14767050400009873
https://www.ncbi.nlm.nih.gov/pubmed/15590442 (abre nova janela)
Mesoporfirina de estanho
Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. (abre nova janela)
Fonte: J Perinatol 2016;36(7):533-9.
Indexado: PubMed 26938918
DOI: 10.1038/jp.2016.22
https://www.ncbi.nlm.nih.gov/pubmed/26938918 (abre nova janela)
Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. (abre nova janela)
Fonte: Pediatrics 2001;108(6):1374-7.
Indexado: PubMed 11731664
https://www.ncbi.nlm.nih.gov/pubmed/11731664 (abre nova janela)
A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. (abre nova janela)
Fonte: Pediatrics 2004;113(1 Pt 1):119-23.
Indexado: PubMed 14702459
https://www.ncbi.nlm.nih.gov/pubmed/14702459 (abre nova janela)
Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. (abre nova janela)
Fonte: J Perinatol 2003;23(6):507-8.
Indexado: PubMed 13679941
DOI: 10.1038/sj.jp.7210943
https://www.ncbi.nlm.nih.gov/pubmed/13679941 (abre nova janela)
Outros agentes
Phenobarbitone for prevention and treatment of unconjugated hyperbilirubinemia in preterm neonates: a systematic review and meta-analysis. (abre nova janela)
Fonte: Indian Pediatr 2010;47(5):401-7.
Indexado: PubMed 19736369
https://www.ncbi.nlm.nih.gov/pubmed/19736369 (abre nova janela)
Single dose of 50 mg/kg clofibrate in jaundice of healthy term neonates: randomised clinical trial of efficacy and safety. (abre nova janela)
Fonte: Indian J Pediatr 2012;79(2):194-7.
Indexado: PubMed 21785863
DOI: 10.1007/s12098-011-0531-9
https://www.ncbi.nlm.nih.gov/pubmed/21785863 (abre nova janela)
Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. (abre nova janela)
Fonte: J Pediatr Gastroenterol Nutr 2016;62(1):97-100.
Indexado: PubMed 26020375
DOI: 10.1097/MPG.0000000000000874
https://www.ncbi.nlm.nih.gov/pubmed/26020375 (abre nova janela)
Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. (abre nova janela)
Fonte: Pediatrics 2009;124(4):1193-8.
Indexado: PubMed 19786452
DOI: 10.1542/peds.2009-0329
https://www.ncbi.nlm.nih.gov/pubmed/19786452 (abre nova janela)
A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. (abre nova janela)
Fonte: J Pediatr 2005;147(6):781-5.
Indexado: PubMed 16356431
DOI: 10.1016/j.jpeds.2005.07.026
https://www.ncbi.nlm.nih.gov/pubmed/16356431 (abre nova janela)
Treatment of clofibrate in jaundiced low birth weight neonates. [English, Turkish abstract] (abre nova janela)
Fonte: UHOD-Uluslar Hematol Onkol De (Int J Hematol Oncol) 2009;19(2):100-5.
Indexado: EMBASE 2009472903
http://www.uhod.org/summary_en.php3?id=359 (abre nova janela)
Clofibrate for unconjugated hyperbilirubinemia in neonates: a systematic review. (abre nova janela)
Fonte: Indian Pediatr 2012;49(1):35-41.
Indexado: PubMed 22318100
https://www.ncbi.nlm.nih.gov/pubmed/22318100 (abre nova janela)
Interscapular site for transcutaneous bilirubin measurement in preterm infants: a better and safer screening site. (abre nova janela)
Fonte: J Perinatol 2014;34(3):209-12.
Indexado: PubMed 24406742
DOI: 10.1038/jp.2013.167
https://www.ncbi.nlm.nih.gov/pubmed/24406742 (abre nova janela)
Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). (abre nova janela)
Fonte: Southeast Asian J Trop Med Public Health 2008;39(3):557-61.
Indexado: PubMed 18564698
https://www.ncbi.nlm.nih.gov/pubmed/18564698 (abre nova janela)